GET THE APP
+44-73-6204-9920
editorial@journalres.com
Submit Manuscript
Language
Spanish
Chinese
Russian
German
French
Japanese
Portuguese
Hindi
Telugu
Tamil
Journal of Multiple Sclerosis
ISSN - 2376-0389
NLM - 101654564
Navbar
Journal Home
Editorial Board
Author Guidelines
Aim & Scope
Instruction For Authors
Author Guidelines
Peer Review Process
Publication Ethics & Malpractice Statement
Articles in process
Archive
Submit Manuscript
Journal Contact
Volume 9, Issue 3, 2022
Mini Review
Pages: 1 - 3
A Review of Olfactory Dysfunction and Neurological Disorders
Maria Richards
*
Abstract
Editorial Note
Pages: 1 - 2
Pathogenesis, Symptoms, Diagnosis, and Cell-Based Therapy for Multiple Sclerosis
Elyna Joy
*
PDF
Editorial Note
Pages: 1 - 2
From the Bench to the Bedside in Multiple Sclerosis: Concepts in Pathophysiology and Their Potential Impact on Patients
Elyna Joy
*
PDF
Opinion
Pages: 1 - 1
In Resource-Constrained Situations, Low-Dose Rituximab Should Be Utilised To Treat Ms: No
Elyna Joy
*
PDF
Opinion Article
Pages: 1 - 1
The Efficacy and Hazards of All Bruton's Tyrosine Kinase Inhibitors are the Same: No
Elyna Joy
*
PDF
Journal Highlights
Advance Treatment for Multiple Sclerosis
Alcoholic Neuropathy
Demyelination
Disseminated Sclerosis
Encephalomyelitis Disseminate
Essential Tremor
Immune-Mediated Disease
Manic-Depressive illness
Motor Neuron Disease
Multiple sclerosis (MS) Medications
Multiple Sclerosis Diagnosis
Multiple Sclerosis Physical Therapy
Myelin Repair
Neurodegenerative Diseases
Neuroimmunological Disorders
Neuromyelitis Optica
Neurorehabilitation
Progressive Multifocal Leukoencephalopathy
Journal Flyer
+44-73-6204-9920
Tweets by Sclerosis_IOMC
Top
